These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8615175)

  • 21. Probing the world of cytochrome P450 enzymes.
    Frye RF
    Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes.
    Gillam EM
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):147-52. PubMed ID: 15743395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique cytochromes P450 in human brain: implication in disease pathogenesis.
    Ravindranath V; Kommaddi RP; Pai HV
    J Neural Transm Suppl; 2006; (70):167-71. PubMed ID: 17017525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extending the capabilities of nature's most versatile catalysts: directed evolution of mammalian xenobiotic-metabolizing P450s.
    Gillam EM
    Arch Biochem Biophys; 2007 Aug; 464(2):176-86. PubMed ID: 17537393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The small intestine as a xenobiotic-metabolizing organ.
    Kaminsky LS; Zhang QY
    Drug Metab Dispos; 2003 Dec; 31(12):1520-5. PubMed ID: 14625348
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component.
    Perez-Pastene C; Graumann R; Díaz-Grez F; Miranda M; Venegas P; Godoy OT; Layson L; Villagra R; Matamala JM; Herrera L; Segura-Aguilar J
    Neurosci Lett; 2007 May; 418(2):181-5. PubMed ID: 17403576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial DNA in Parkinson's disease.
    Schapira AH
    Adv Neurol; 1999; 80():233-7. PubMed ID: 10410727
    [No Abstract]   [Full Text] [Related]  

  • 28. [Genetic polymorphisms of cytochrome P450 1A1 and susceptibility of early-onset Parkinson's disease].
    Liu P; Liu Z; Shao M; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):283-5. PubMed ID: 11484167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Association between the debrisoquine hydroxylase gene polymorphism and the genetic susceptibility of Parkinson's disease].
    Tao E; Liu Z; Chen B; Pan X; Shao M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):281-3. PubMed ID: 9758873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M; Pelkonen O
    IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD.
    Hukkanen J; Pelkonen O; Raunio H
    Eur Respir J Suppl; 2001 Sep; 32():122s-126s. PubMed ID: 11816819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plant monooxygenases: participation in xenobiotic oxidation.
    Khatisashvili G; Gordeziani M; Kvesitadze G; Korte F
    Ecotoxicol Environ Saf; 1997 Mar; 36(2):118-22. PubMed ID: 9126428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment.
    Snawder JE; Lipscomb JC
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):200-9. PubMed ID: 11067776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil.
    Spitz M; Rozenberg R; Pereira Lda V; Reis Barbosa E
    Parkinsonism Relat Disord; 2008; 14(1):58-62. PubMed ID: 17703984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease.
    Steventon GB; Sturman S; Waring RH; Williams AC
    Drug Metabol Drug Interact; 2001; 18(2):79-98. PubMed ID: 11460878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease and cytochrome P450: a possible link?
    Shahi GS; Das NP; Moochhala SM
    Med Hypotheses; 1990 Aug; 32(4):277-82. PubMed ID: 2233418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xenobiotic metabolism in idiopathic Parkinson's disease in Nigerian Africans.
    Igbokwe E; Ogunniyi AO; Osuntokun BO
    East Afr Med J; 1993 Dec; 70(12):807-9. PubMed ID: 8026358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal liver enzyme-mediated metabolism in Parkinson's disease: a second look.
    Tanner CM
    Neurology; 1991 May; 41(5 Suppl 2):89-91; discussion 92. PubMed ID: 2041601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional consequences of polymorphism of xenobiotic metabolising enzymes.
    Ingelman-Sundberg M
    Toxicol Lett; 1998 Dec; 102-103():155-60. PubMed ID: 10022248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promiscuous regulator of xenobiotic removal.
    Schuetz E; Strom S
    Nat Med; 2001 May; 7(5):536-7. PubMed ID: 11329050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.